UMSARS versus laryngoscopy-based assessment of dysphagia
Objective: To compare the Unified Multiple System Atrophy Rating Scale (UMSARS) part I-item 2 with an ear/nose/throat (ENT) expert physician assessment. Background: Early and severe…Jerky dystonic hand revisited: post-stroke thalamic tremor
Objective: To assess phenomenology and clinical- radiological correlation of post thalamic stroke movement disorders (MDs) Background: Post stroke movement disorders (PSMD) are rare and have…Foslevodopa/foscarbidopa in patients with advanced Parkinson’s disease: subgroup analyses from a phase 3, randomized study
Objective: Present the efficacy and safety of 24-hour/day continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) across pre-specified subgroups (age, sex, body mass index [BMI], race,…Analysis of the network of genes related to Parkinson’s and identification of key proteins
Objective: Parkinson's disease (PD) is one of the increasing age-related diseases with no definite treatment. PD is considered as a disorder with genetic and non-genetic…Needs assessment of patients with Parkinson’s disease: a qualitative study
Objective: This research was conducted with a qualitative approach to assess the needs of patients with Parkinson's disease Background: In the health system, the provision…Connectivity Profile for Deep Brain Stimulation in Early-Stage Parkinson’s Disease
Objective: To describe the relationship between stimulation location and motor progression for the deep brain stimulation (DBS) in early-stage Parkinson’s disease (PD) pilot trial cohort…Tremor Reduction Using DBS: Outcomes of a Real-world, Prospective, Multicenter Essential Tremor Registry
Objective: In this report, preliminary data will be presented from a prospective, multicenter, international Essential Tremor (ET) outcomes study in which patients received a multiple…Predicting motor outcome and quality of life after subthalamic DBS for Parkinson’s Disease: the role of standard screening measures and wearable-data
Objective: To evaluate the utility of universal components incorporated in the DBS screening, complemented by a wearable sensor, to predict motor outcomes and Quality of…Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease
Objective: To report the efficacy and safety profiles of patients on sustained foslevodopa/foscarbidopa (LDP/CDP) continuous subcutaneous infusion (CSCI) mono- or polytherapy from three phase 3…Asymptomatic Gaucher disease presented as Parkinsonism in 61 years old patient.
Objective: Gaucher disease is an inherited disease caused by a mutation in the glucocerebrosidase gene, causing visceral, hematologic, and skeletal involvement. [1] [2] We report…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 1374
- Next Page »